Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.65% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
ADS-TEC Energy
ADSE
$880M
| $286K | ﹤0.01% |
22,800
-1,800
| -7% | -$19.6K |
|
|
VIGL
2927
DELISTED
Vigil Neuroscience
VIGL
| $286K | ﹤0.01% |
71,500
+11,536
| +19% | +$39.5K |
|
|
USAS
2928
Americas Gold and Silver
USAS
$1.78B
| $286K | ﹤0.01% |
477,960
+461,513
| +2,806% | +$325K |
|
|
SWKH
2929
DELISTED
SWK Holdings
SWKH
| $285K | ﹤0.01% |
21,202
+379
| +2% | +$5.16K |
|
2930
Clear Channel Outdoor Holdings
CCO
$1.19B
| $285K | ﹤0.01% |
202,392
-551,696
| -73% | -$814K |
|
2931
Ebang International Holdings
EBON
$11.8M
| $283K | ﹤0.01% |
45,713
+900
| +2% | +$7.21K |
|
|
FPAY
2932
DELISTED
FlexShopper
FPAY
| $282K | ﹤0.01% |
220,590
+50,847
| +30% | +$58.6K |
|
|
ORKA
2933
Oruka Therapeutics
ORKA
$7.06B
| $280K | ﹤0.01% |
6,092
+617
| +11% | +$24.6K |
|
2934
State Street SPDR S&P Dividend ETF
SDY
$22.2B
| $280K | ﹤0.01% |
2,200
-12,400
| -85% | -$1.6M |
|
2935
Xilio Therapeutics
XLO
$60.1M
| $280K | ﹤0.01% |
21,071
+3,253
| +18% | +$50.9K |
|
2936
SCYNEXIS
SCYX
$51.4M
| $278K | ﹤0.01% |
17,375
-27,155
| -61% | -$420K |
|
2937
KLX Energy Services
KLXE
$35.7M
| $277K | ﹤0.01% |
56,000
-2,000
| -3% | -$12K |
|
|
STKL
2938
DELISTED
SunOpta
STKL
| $277K | ﹤0.01% |
+51,275
| New | +$301K |
|
2939
Palladyne AI
PDYN
$320M
| $275K | ﹤0.01% |
172,174
+76,396
| +80% | +$131K |
|
|
TVRD
2940
Tvardi Therapeutics
TVRD
$24.9M
| $275K | ﹤0.01% |
29,604
-7,409
| -20% | -$177K |
|
2941
Broadwind
BWEN
$126M
| $275K | ﹤0.01% |
83,800
+33,064
| +65% | +$98.8K |
|
|
DMRA
2942
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.84B
| $275K | ﹤0.01% |
23,172
+13
| +0.1% | +$205 |
|
2943
Inseego
INSG
$78.8M
| $274K | ﹤0.01% |
+25,717
| New | +$150K |
|
2944
Intrepid Potash
IPI
$493M
| $273K | ﹤0.01% |
11,671
-8,639
| -43% | -$199K |
|
2945
Zions Bancorporation
ZION
$10.6B
| $273K | ﹤0.01% |
6,300
-398,195
| -98% | -$16.8M |
|
|
NOTV
2946
DELISTED
Inotiv
NOTV
| $273K | ﹤0.01% |
164,164
+37,800
| +30% | +$139K |
|
2947
Sana Biotechnology
SANA
$1.06B
| $272K | ﹤0.01% |
49,900
-123,000
| -71% | -$980K |
|
2948
Suzano
SUZ
$9.9B
| $269K | ﹤0.01% |
26,216
-229,558
| -90% | -$2.41M |
|
2949
Aligos Therapeutics
ALGS
$41.1M
| $269K | ﹤0.01% |
30,754
-1,576
| -5% | -$27.7K |
|
2950
Paramount Gold Nevada
PZG
$133M
| $268K | ﹤0.01% |
670,904
+314,304
| +88% | +$145K |
|
Similar funds
Jim Simons's Q2 2024 Portfolio in Review
As of Q2 2024, Jim Simons held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $4.49B in Q2 2024, closing 674 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Broadcom worth $472M.
- Jim Simons's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Jim Simons added most to Apple in Q2 2024, an estimated $244M increase.
- Jim Simons's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Jim Simons fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Jim Simons's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Jim Simons opened 463 new positions and closed 674 in Q2 2024.
- Jim Simons's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.